Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying 61 - 72 of 436
General Hepatology

EASL Studio: The bumpy road of Hepatitis B drug development successes and challenges

EASL Studio
View
General Hepatology

EASL Studio: Clinical trials in rare diseases – opportunities and challenges

EASL Studio
View
General Hepatology

EASL Studio: What does the future look like for patients with NAFLD?

EASL Studio
View
General Hepatology

EASL Studio:Liver cirrhosis in 2023: unmet needs and how to address them? (Complete Session)

EASL Studio
View
General Hepatology

EASL Studio: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio
View
General Hepatology

EASL Studio Opening

EASL Studio
View
General Hepatology

EASL Studio: Practice changing highlights from EASL Congress 2023

EASL Studio
View
General Hepatology

EASL Studio: Steatotic liver disease global consensus to change nomenclature

EASL Studio
View
General Hepatology

EASL Studio: EASL Congress 2023: Back to the future

EASL Studio
View
General Hepatology

EASL Studio: Highlights of liver cancer research at EASL Congress 2023

EASL Studio
View
General Hepatology

EASL Studio: United we stand: Global societies collaborating to beat liver disease

EASL Studio
View
Cirrhosis & Complications
EASL Studio Podcast S5 E14: Hepatic encephalopathy: Underdiagnosed and underestimated

EASL Studio Podcast S5 E14: Hepatic encephalopathy: Underdiagnosed and underestimated

Podcasts
View
Displaying 61 - 72 of 436